Reversible Perfusion Changes during Acute Attacks in Glucose Transporter Type 1 Deficiency Syndrome: A Pediatric Case

Francesco Pacchiano1, Chiara Doneda2, Filippo Arrigoni2

  • 1From the Department of Precision Medicine (F.P.), University of Campania "L. Vanvitelli," Caserta, Italy fpacchiano1@gmail.com.

Insights

Glucose transporter type 1 deficiency syndrome (GLUT1-DS) causes infantile seizures and movement disorders. New imaging reveals reversible brain hypoperfusion during stroke-like episodes, aiding understanding of GLUT1-DS acute symptoms.

Area of Science:

  • Neurology
  • Pediatrics
  • Medical Imaging

Background:

  • Glucose transporter type 1 deficiency syndrome (GLUT1-DS) is an infantile-onset disorder linked to SLC2A1 gene mutations.
  • Clinical features include seizures, developmental delay, movement disorders, and stroke-like episodes.
  • The underlying pathomechanism of acute transient symptoms in GLUT1-DS remains unclear, with standard MRI often showing nonspecific findings.

Purpose of the Study:

  • To investigate the acute pathophysiological changes during stroke-like episodes in pediatric patients with GLUT1-DS.
  • To evaluate the utility of arterial spin-labeling (ASL) perfusion imaging and magnetic resonance angiography (MRA) in characterizing these events.

Main Methods:

  • ASL perfusion imaging and MRA were performed during acute stroke-like episodes in 4 pediatric patients with GLUT1-DS.
  • Imaging findings were analyzed to identify perfusion abnormalities and vascular changes.

Main Results:

  • Reversible hypoperfusion was observed in the affected cerebral hemisphere.
  • Reversible attenuation of distal Middle Cerebral Artery (MCA) branches was noted on MRA.
  • A correlation between unilateral cerebral hypoperfusion and transient crossed cerebellar diaschisis was identified on perfusion maps.

Conclusions:

  • ASL and MRA can detect reversible perfusion deficits and vascular changes during acute stroke-like episodes in GLUT1-DS.
  • These findings suggest that transient hypoperfusion plays a role in the acute neurological manifestations of GLUT1-DS.
  • Advanced imaging techniques offer insights into the poorly understood pathomechanism of acute symptoms in this syndrome.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.4K
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K